mFOLFIRINOX

Eileen M. O’Reilly: Adjuvant mFOLFIRINOX for Resected Pancreatic Adenocarcinoma

Eileen M. O’Reilly, Oncologist at Memorial Sloan Kettering Cancer Centre, shared on X:

“Adjuvant mFOLFIRINOX for Resected Pancreatic Adenocarcinoma (PDAC): Clinical Insights and Genomic Features from a Large Contemporary Cohort.

Congrats to Fergus Keane, Catherine O’Connor, Fiyinfolu (Folu) Balogun, Drew Moss, for very thoughtful compilation synthesis of data!”

Adjuvant Modified FOLFIRINOX for Resected Pancreatic Adenocarcinoma (PDAC): Clinical Insights and Genomic Features from a Large Contemporary Cohort.

Authors: Fergus Keane, Catherine O’Connor, Drew Moss, Joanne F Chou, Maria A Perry, Fionnuala Crowley, Parima Saxena, Amelia Chan, Joshua D Schoenfeld, Anupriya Singhal, Wungki Park, Darren Cowzer, Emily Harrold, Anna M Varghese, Imane El Dika, Christopher Crane, James J Harding, Ghassan K Abou-Alfa, T Peter Kingham, Alice C Wei, Kenneth H Yu, Michael I D’Angelica, Vinod P Balachandran, Jeffrey Drebin, William R Jarnagin, Chaitanya Bandlamudi, David Kelsen, Marinela Capanu, Kevin C Soares, Fiyinfolu Balogun, Eileen M O’Reilly.

mFOLFIRINOX

Alice C. Wei Amelia Chan Anna M. Varghese Anupriya Singhal cancer Catherine O’Connor Chaitanya Bandlamudi Christopher Crane Darren Cowzer David Kelsen Drew Moss Eileen M. O'Reilly Emily Harrold Fergus Keane Fionnuala Crowley Fiyinfolu (Folu) Balogun Fiyinfolu Balogun Ghassan K. Abou-Alfa Imane El Dika James J. Harding Jeffrey Drebin Joanne F. Chou Joshua D Schoenfeld Kenneth H Yu Kevin C Soares Maria A Perry Marinela Capanu Memorial Sloan Kettering Cancer Centre mFOLFIRINOX Michael I. D’Angelica OncoDaily Oncology pancreatic adenocarcinoma Parima Saxena T. Peter Kingham Vinod P. Balachandran William R. Jarnagin Wungki Park